Monthly Archives: February 2025

• 

FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans

By Sharon Deveson Kell|2025-02-27T08:46:24+00:0027 Feb 2025|Drug treatments|

The Food and Drug Administration (FDA) in America has accepted [...]

Read More

Comments Off on FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans

• 

Kidney cancer research highlights from ASCO GU 2025

By Sharon Deveson Kell|2025-02-25T15:57:42+00:0025 Feb 2025|Cancer news|

Every year, researchers from around the world gather at a [...]

Read More

Comments Off on Kidney cancer research highlights from ASCO GU 2025

• 

Spotting symptoms early: the importance of early diagnosis

By Sharon Deveson Kell|2025-02-27T08:41:17+00:0019 Feb 2025|Cancer news|

Cancer Research UK have been highlighting the importance of screening [...]

Read More

Comments Off on Spotting symptoms early: the importance of early diagnosis

• 

Cancer Research UK – 74,000 cancer patients not treated on time in 2024

By Sharon Deveson Kell|2025-02-13T14:42:32+00:0013 Feb 2025|Patient advocacy|

A new analysis by Cancer Research UK revealed that in [...]

Read More

Comments Off on Cancer Research UK – 74,000 cancer patients not treated on time in 2024

• 

New personalised cancer vaccine shows promise for advanced kidney cancer

By Sharon Deveson Kell|2025-02-06T17:08:07+00:006 Feb 2025|Drug treatments|

A new personalised cancer vaccine has shown promising anti-tumour immunity [...]

Read More

Comments Off on New personalised cancer vaccine shows promise for advanced kidney cancer